Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

438 PHENYTOIN
(1995): Perlik F+, Ther Drug Monit 17(5), 445
(1994): Tigaran S, Acta Neurol Scand 90(5), 367
(1993): Lipton JM+, J Indiana Dent Assoc 72, 18
(1992): Romanos GE+, JOralPatholMed21(6), 256
(1992): Thomason JM+, Community Dent Oral Epidemiol
20(5), 288
(1991): Brown RS+, Oral Surg Oral Med Oral Pathol 71(5), 565
(1991): Dahllof G+, Swed Dent J 15(3), 139
(1991): Hassell TM+, Crit Rev Oral Biol Med 2, 103
(1990): Hall WB, Compendium (Suppl) 14, 502
(1990): Kinane DF+, Arch Oral Biol 35(7), 561
(1990): Levratti E+, Minerva Ortognatod 8(2), 103
(1990): Penarrocha-Diago M+, JPeriodontol61(9), 571
(1989): Backman K+, Scand J Dent Res 97, 222
(1989): Dooley G+, J N Z Soc Periodontol 68, 19
(1989): Pugliesi NS+, Rev Faculdade Odontol FZL 1(2), 97
(1987): Norris JF+, Int J Dermatol 26, 602
(1987): Stinnett E+, J Am Dent Assoc 114, 814
Mucocutaneous eruption
(1992): Tone T+, JDermatol19, 27
Mucocutaneous lymph node syndrome (Kawasaki
syndrome)
Oral ulceration
(2003): Misra UK+, Postgrad Med J 79(938), 703 (with
carbamazepine)
Hair
Hair – alopecia
(2001): Mangalvedhekar SS+, J Assoc Physicians India 49, 929
(1984): Smith DA+, JAmAcadDermatol10, 106
Hair – hirsutism
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
(1989): Backman K+, Scand J Dent Res 97, 222
(1989): Vivard P+, Ann Dermatol Venereol (French) 116, 562
Hair – hypertrichosis
(2001): Oakley A, Hamilton, New Zealand (from Internet)
(observation)
(1989): Rousseau C+, Dermatologica 179, 221
Nails
Nails – changes (sic)
(1981): Krebs A, Schweiz Rundsch Med Prax (German) 70, 1951
Nails – hypoplasia
(1991): D’Souza SW+, Arch Dis Child 66, 320
(1981): Johnson RB+, JAmAcadDermatol5, 191
Nails – onychopathy
(1988): Verdeguer JM+, Pediatr Dermatol 5, 56
Nails – pigmentation
(1981): Johnson RB+, JAmAcadDermatol5, 191
Eyes
Dyschromatopsia
(2003): Thakral A+, Acta Neurol Belg 103(4), 218
Nystagmus
(2006): Jenkins A, Palliat Med 20(4), 479
Vision blurred
(2003): Thakral A+, Acta Neurol Belg 103(4), 218
Visual hallucinations
(2007): Kemper EM+, Ned Tijdschr Geneeskd 151(2), 138
Other
Acromegaloid features
Anticonvulsant hypersensitivity syndrome
(9999):
(2005): Amato A+, Am J Health Syst Pharm 62(21), 2295
(2005): Cheung E+, J Child Neurol 20(2), 157
(2005): Subbannan K+, South Med J 98(9), 937
(2005): Zaidi AN, Can J Clin Pharmacol 12(1), e33
(2004): Papp Z+, Orv Hetil 145(32), 1665
(2002): Kaur S+, Pediatr Dermatol 19(2), 142
(1997): Morkunas AR+, Crit Care Clin 13(4), 727
(1995): Vittorio CC+, Arch Intern Med 155(21), 2285
Application-site pain
(2002): Coplin WM+, Neurol Res 24(8), 842
Coarse facies
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
(2003): Scheinfeld N, Dermatol Online J 9(3), 6
Death
DRESS syndrome
(2006): Kim CW+, J Korean Med Sci 21(4), 768
(2006): Mendiratta V+, Clin Exp Dermatol 31(5), 720
(2004): Allam JP+, Eur J Dermatol 14(5), 339
Fetal hydantoin syndrome*
(1998): Ozkinay F+, Turk J Pediatr 40, 273 (2 siblings)
(1994): Buehler BA+, Neurol Clin 12, 741
(1989): Nanda A+, Pediatr Dermatol 6, 130
(1989): Nanda A+, Pediatr Dermatol 6, 66
(1988): Verdeguer JM+, Pediatr Dermatol 5, 56
(1983): Tomsick RS, Cutis 32, 535
(1981): Nagy R, Arch Dermatol 117, 593
Gynecomastia
(1998): Ikeda A+, J Neurol Neurosurg Psychiatry 65, 803
Hepatotoxicity
(2003): Altuntas Y+, South Med J 96(2), 201
Hypersensitivity
(2006): Campoamor Serrano MT+, An Med Interna 23(4), 194
(2006): Seitz CS+, Ann Allergy Asthma Immunol 97(5), 698
(2005): Bedimo RJ+, IntJSTDAIDS16(2), 178
(2005): Yigit S+, Pediatr Dermatol 22(1), 71
(2004): Criado PR+, JDermatol31(12), 1009
(2004): Mostella J+, South Med J 97(3), 319
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
(2004): Singh G+, J Neurol Neurosurg 75(2), 331 (4 cases)
(2002): Metin A+, World Congress Dermatol Poster, 0116
(2002): Monks G+, J Drugs Dermatol 1(2), 199
(2002): Nagai Y+, JDermatol29(10), 670
(2001): Aihara M+, Br J Dermatol 144, 1231
(2001): Bessmertny O+, Ann Pharmacother 35(5), 533
(2001): Gungor E+, Neurol Sci 22(3), 261
(2001): Klassen BD+, Epilepsia 42(3), 433
(2001): Nashed MH+, Pharmacotherapy 21(4), 502
(2000): Cohen AD+, Isr Med Assoc J 1, 95
(2000): Colombo-Arnet E, Schweiz Rundsch Med Prax (German)
89, 675
(2000): Lynfield Y, Brooklyn, NY (from Internet) (observation)
(2000): Moore SJ+, JMedGenet37, 489
(2000): Troger U+, Int J CLin Pharmacol Ther 38(9), 452
(1999): Hamer HM+, Seizure 8, 190
(1999): Moss DM+, J Emerg Med 17, 503
(1999): Quinones MD+, Allergy 54, 83 (fatal)
(1998): Galindo Bonilla PA+, J Investig Allergol Clin Immunol
8, 186
(1997): Morkunas AR+, Crit Care Clin 13, 727
(1997): Redondo Bellon P, Rev Neurol 25, S309
(1997): Tennis P+, Neurology 49, 542
(1996): Chopra S+, Br J Dermatol 134, 1109
(1996): Conger LA+, Cutis 57, 223
(1994): Potter T+, Arch Dermatol 130, 856
(1993): Handfield-Jones SE+, Br J Dermatol 129, 175
(1984): Fonseca JC+, Med Cutan Ibero Lat Am (Portuguese)
12, 187
(1983): Rapp RP+, Neurosurgery 13, 272
Injection-site extravasation
(2002): Edwards JJ+, Anesth Analg 94(3), 672
Injection-site necrosis
(1995): Hunt SJ, Am J Dermatopathol 17, 399
(1993): Hayes AG+, JAmAcadDermatol28, 360
Injection-site pain
(2002): Coplin WM+, Neurol Res 24(8), 842